Shift Manager
embecta
Shift Manager
embecta
Manufactures insulin delivery devices worldwide
embecta is a global medical device company with a 100-year legacy in insulin delivery and diabetes care. Driven by innovation, purpose, and a commitment to improving lives, we are expanding our portfolio of solutions to serve even more patients, healthcare providers, and communities around the world.
Ready to lead a high-performing team in a fast-paced, highly automated manufacturing environment? As Shift Manager, you’ll take ownership of production performance across Safety, Quality, Delivery, Cost and People, while leading, coaching and developing a large team within our 24/7 operation. This is a hands-on leadership role where you’ll solve problems, drive continuous improvement and help shape a strong culture of safety, quality, accountability and engagement.
Your key responsibilities will include:
What you’ll bring
We’re looking for someone who combines strong people leadership with practical manufacturing experience and the ability to build an engaged, high-performing team.
Education and experience
Knowledge, skills and capabilities
We offer a Total Rewards package that includes a competitive base salary, Health Insurance , Global Shares and Incentive Program , Pension, Income Continuance Insurance and other Life Assurance related programs.
#LI-DF1
#LI-ONSITE
embecta is an Equal Opportunity/Affirmative Action Employer. We do not unlawfully discriminate on the basis of race, color, religion, age, sex, creed, national origin, ancestry, citizenship status, marital or domestic or civil union status, familial status, affectional or sexual orientation, gender identity or expression, genetics, disability, military eligibility or veteran status, or any other protected status.
Embecta designs, manufactures, and sells insulin delivery devices such as pen needles, insulin syringes, and safety injection devices for diabetes patients around the world. Its products are used to inject insulin and include disposable components like Nano and Ultra-Fine needles, with a tubeless insulin patch pump once pursued but later refocused on core injection devices. The company differentiates itself as a dedicated diabetes injection devices supplier with a global manufacturing footprint and an established distribution network, originating as a BD spin-off. Embecta aims to grow through strategic expansion, including an announced plan to acquire Owen Mumford to broaden into drug-delivery platforms beyond diabetes.
Explore more opportunities at embecta